Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Research and Development Funding for FY 2016
- Contact Congress (Legislative Action Center)
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Congressional Science Fellowship
Check Here for Critical Public Policy Information
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
Public and Scientific Affairs Board (PSAB)
Underlying the ASM's dedication to the advancement of scientific knowledge is its commitment that science serve the public interest. To address scientific matters affecting the public interest, the ASM created the Public and Scientific Affairs Board (PSAB) in 1979. The PSAB monitors legislation and regulation and develops positions for the Society on public policy issues. The PSAB encourages the adoption of sound policies affecting science and technology and the discipline of microbiology. The PSAB responds to policy makers who may request or require an understanding of research and technology in microbiology. It also communicates microbiological issues to the public.
What's New in Public Policy?
On March 27, 2015 the White House released a comprehensive plan that identifies critical actions to be taken by Federal departments and agencies to combat the rise of antibiotic-resistant bacteria.
Biomedical and Life Sciences Research - Federal Funding for FY 2016 A compilation of the ASM recommendations to Congress for FY 2016 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Food and Drug Administration, and science funding in the National Science Foundation,...
The ASM sent a letter to Sylvia Mathews Burwell, Secretary of Health and Human Services, Department of Health and Human Services regarding CDC Biosafety recommendations.
The ASM submitted FY 2016 appropriations recommendations to the House and Senate Appropriations Committees.
The Office of Science and Technology Policy released a request for comment on regarding the impact that the Select Agent Regulations (SAR) have had on science, technology, and national security, and on the benefits, costs, and limitations of these regulations.
The March issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities.
The February issue of the e-Public Policy Update has been published by the Office of Public Affairs.
The January/February issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.
January 28, 2015 - ASM Statement on the President’s Proposed 2016 Budget to Combat Antibiotic-Resistant Bacteria
The ASM released a statement on the President’s Proposed 2016 Budget to Combat Antibiotic-Resistant Bacteria.
The ASM sent a letter to Senator Richard Durbin (D-IL) endorsing the bill which would provide a five percent increase in funding for biomedical research supported by the National Institutes of Health and other federal agencies involved in biomedical research.